Recent therapeutic reviews have reported the pivotal role of the PI3K/Akt signaling pathway in Alzheimer’s disease (AD) pathogenesis and its potential as a therapeutic target62,63. The gene discussed is AKT1; the disease is early-onset autosomal dominant Alzheimer disease.